Stock listing

NASDAQ:FMI Foundation Medicine Inc Stock

Follow Foundation Medicine Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FMI

$137.00 USD

Close on Jul 31, 2018 · No longer trades

Sep 25, 2013 to last close +287.6% · weekly closes, Sep 25, 2013 – Jul 31, 2018
Lowest – highest close
$13.71 – $137.00 USDSince Sep 25, 2013 · lowest Feb 9, 2016 · highest Jul 30, 2018

Delisted NASDAQ:FMI no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FMI
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Foundation Medicine Inc news

Foundation Medicine Inc on 6ix

News releases
1 in the last 12 months · 1 in all · newest Nov 16, 2026 · oldest 2026
Decks
6 decks · latest Jan 8, 2018

Decks

DeckKindSlidesDate
JP Morgan Healthcare Conference 2018Conference20 slidesJan 8, 2018
J.P. Morgan Healthcare Conference (January 2017)Conference17 slidesJan 9, 2017
2016 J.P. Morgan Annual Healthcare ConferenceConference22 slidesJan 11, 2016
Merger or Acquisition (January 2015)Merger or acquisition49 slidesJan 14, 2015
Merger or Acquisition (January 2015)Merger or acquisition20 slidesJan 12, 2015
Investor Presentation (January 2014)Investor deck28 slidesJan 13, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sandra J. Horning
Other companies: Revolution Medicines, Inc. (Director · Since at least Nov 9, 2023); Olema Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2020); Moderna, Inc. (Director · Since at least Apr 29, 2020); Gilead Sciences, Inc. (Director · Since at least Jan 28, 2020); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past)
Director · Apr 7, 2015 – Apr 7, 2015 · Past
Brook H Byers
Other companies: CareDx, Inc. (Director · Jul 16, 2014 – Apr 1, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – May 17, 2016 · Past); Genomic Health Inc (Director · May 25, 2006 – Apr 1, 2011 · Past)
Director · Sep 24, 2013 – Apr 7, 2015 · Past
Evan Jones
Other companies: Veracyte, Inc. (Board Member · Since at least Oct 29, 2013); CapForce Inc. (Director · May 4, 2015 – May 17, 2021 · Past); CAS Medical Systems Inc (Director · Jun 20, 2012 – Jun 24, 2013 · Past); Standard BioTools Inc. (Director · Dec 12, 2011 – Jul 31, 2017 · Past)
Director · Sep 24, 2013 – Jul 31, 2018 · Past
Jason Ryan
Other companies: GeneDx Holdings Corp. (Director · Since at least Jul 22, 2021); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Dianthus Therapeutics, Inc. (See Remarks · Jan 1, 2019 – Feb 10, 2020 · Past)
Chief Financial Officer · Sep 24, 2013 – Jul 31, 2018 · Past
Krishna Yeshwant
Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Verve Therapeutics Inc (Director · Since at least Jun 16, 2021); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past)
Director · Jun 16, 2016 – Jul 31, 2018 · Past
Mark J Levin
Other companies: Fulcrum Therapeutics, Inc. (Director · Jul 17, 2019 – Nov 10, 2021 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 3, 2021 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Mar 20, 2014 · Past)
Director · Sep 24, 2013 – May 12, 2014 · Past
David Daly
Other companies: NeoGenomics, Inc. (Director · Nov 10, 2021 – Jun 10, 2022 · Past); Singular Genomics Systems Inc (President and Chief Operating · May 26, 2021 – Mar 4, 2022 · Past)
Chief Commercial Officer · Dec 2, 2014 – Aug 9, 2017 · Past
Michael Varney
Other companies: Erasca, Inc. (Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021); Pardes Biosciences Inc (Director · Dec 23, 2021 – Aug 31, 2023 · Past)
Director · Apr 7, 2015 – Apr 7, 2015 · Past
Michael J DohertyHead of Product Development · Jun 20, 2017 – Jul 31, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Foundation Medicine Inc.